Inventor
POWERS GORDON
US20 patents
⚠️ This page may combine multiple inventors who share the name “POWERS GORDON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
9 patentsUS11014987B2May 25, 2021
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
JANSSEN PHARMACEUTICA NV9 citations83
US10273301B2Apr 30, 2019
Anti-vista antibodies and fragments
JANSSEN PHARMACEUTICA NV7 citations83
US10899836B2Jan 26, 2021
Method of identifying anti-VISTA antibodies
JANSSEN PHARMACEUTICA NV6 citations81
US11009509B2May 18, 2021
Anti-VISTA antibodies and fragments
JANSSEN PHARMACEUTICA NV7 citations80
US11987630B2May 21, 2024
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
JANSSEN PHARMACEUTICA NV4 citations72
US11242392B2Feb 8, 2022
Anti-vista antibodies and fragments
JANSSEN PHARMACEUTICA NV4 citations72
US12188938B2Jan 7, 2025
Anti-VISTA antibodies and fragments
JANSSEN PHARMACEUTICA NV4 citations71
US12516122B2Jan 6, 2026
Anti-VISTA antibodies and fragments
JANSSEN PHARMACEUTICA NV0 citations62
US12441801B2Oct 14, 2025
Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying same
JANSSEN PHARMACEUTICA NV0 citations60
IMMUNEXT INC
5 patentsUS12139532B2Nov 12, 2024
Anti-human vista antibodies and use thereof
IMMUNEXT INC4 citations83
US11603403B2Mar 14, 2023
Anti-human vista antibodies and use thereof
IMMUNEXT INC4 citations83
US11649283B2May 16, 2023
Anti-human vista antibodies and use thereof
IMMUNEXT INC4 citations82
US11603402B2Mar 14, 2023
Anti-human vista antibodies and use thereof
IMMUNEXT INC4 citations81
US11525000B2Dec 13, 2022
Anti-human VISTA antibodies and use thereof
IMMUNEXT INC4 citations80
GREIG NIGEL H
2 patentsUS8691864B2Apr 8, 2014
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
GREIG NIGEL H13 citations89
US8258172B2Sep 4, 2012
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
GREIG NIGEL H11 citations89